169 related articles for article (PubMed ID: 23727458)
1. Suppression by Δ(9)-tetrahydrocannabinol of the primary immunoglobulin M response by human peripheral blood B cells is associated with impaired STAT3 activation.
Ngaotepprutaram T; Kaplan BL; Carney S; Crawford R; Kaminski NE
Toxicology; 2013 Aug; 310():84-91. PubMed ID: 23727458
[TBL] [Abstract][Full Text] [Related]
2. Impaired NFAT and NFκB activation are involved in suppression of CD40 ligand expression by Δ(9)-tetrahydrocannabinol in human CD4(+) T cells.
Ngaotepprutaram T; Kaplan BL; Kaminski NE
Toxicol Appl Pharmacol; 2013 Nov; 273(1):209-18. PubMed ID: 23999542
[TBL] [Abstract][Full Text] [Related]
3. Complexes between nuclear factor-κB p65 and signal transducer and activator of transcription 3 are key actors in inducing activation-induced cytidine deaminase expression and immunoglobulin A production in CD40L plus interleukin-10-treated human blood B cells.
Lafarge S; Hamzeh-Cognasse H; Richard Y; Pozzetto B; Cogné M; Cognasse F; Garraud O
Clin Exp Immunol; 2011 Nov; 166(2):171-83. PubMed ID: 21985363
[TBL] [Abstract][Full Text] [Related]
4. Effects of targeted deletion of cannabinoid receptors CB1 and CB2 on immune competence and sensitivity to immune modulation by Delta9-tetrahydrocannabinol.
Springs AE; Karmaus PW; Crawford RB; Kaplan BL; Kaminski NE
J Leukoc Biol; 2008 Dec; 84(6):1574-84. PubMed ID: 18791168
[TBL] [Abstract][Full Text] [Related]
5. IL-21 signalling via STAT3 primes human naive B cells to respond to IL-2 to enhance their differentiation into plasmablasts.
Berglund LJ; Avery DT; Ma CS; Moens L; Deenick EK; Bustamante J; Boisson-Dupuis S; Wong M; Adelstein S; Arkwright PD; Bacchetta R; Bezrodnik L; Dadi H; Roifman CM; Fulcher DA; Ziegler JB; Smart JM; Kobayashi M; Picard C; Durandy A; Cook MC; Casanova JL; Uzel G; Tangye SG
Blood; 2013 Dec; 122(24):3940-50. PubMed ID: 24159173
[TBL] [Abstract][Full Text] [Related]
6. Suppression of the IgM Response by Aryl Hydrocarbon Receptor Activation in Human Primary B Cells Involves Impairment of Immunoglobulin Secretory Processes.
Zhou J; Henriquez J; Crawford R; Kaminski N
Toxicol Sci; 2018 May; 163(1):319-329. PubMed ID: 29462421
[TBL] [Abstract][Full Text] [Related]
7. Differential modulation by delta9-tetrahydrocannabinol (∆9)-THC) of CD40 ligand (CD40L) expression in activated mouse splenic CD4+ T cells.
Ngaotepprutaram T; Kaplan BL; Crawford RB; Kaminski NE
J Neuroimmune Pharmacol; 2012 Dec; 7(4):969-80. PubMed ID: 22851303
[TBL] [Abstract][Full Text] [Related]
8. The RP105/MD-1 complex is indispensable for TLR4/MD-2-dependent proliferation and IgM-secreting plasma cell differentiation of marginal zone B cells.
Nagai Y; Yanagibashi T; Watanabe Y; Ikutani M; Kariyone A; Ohta S; Hirai Y; Kimoto M; Miyake K; Takatsu K
Int Immunol; 2012 Jun; 24(6):389-400. PubMed ID: 22354914
[TBL] [Abstract][Full Text] [Related]
9. TLR7- and TLR9-responsive human B cells share phenotypic and genetic characteristics.
Simchoni N; Cunningham-Rundles C
J Immunol; 2015 Apr; 194(7):3035-44. PubMed ID: 25740945
[TBL] [Abstract][Full Text] [Related]
10. TCDD-mediated suppression of naïve human B cell IgM secretion involves aryl hydrocarbon receptor-mediated reduction in STAT3 serine 727 phosphorylation and is restored by interferon-γ.
Blevins LK; Zhou J; Crawford R; Kaminski NE
Cell Signal; 2020 Jan; 65():109447. PubMed ID: 31678681
[TBL] [Abstract][Full Text] [Related]
11. Toll-like receptor 7-induced naive human B-cell differentiation and immunoglobulin production.
Glaum MC; Narula S; Song D; Zheng Y; Anderson AL; Pletcher CH; Levinson AI
J Allergy Clin Immunol; 2009 Jan; 123(1):224-230.e4. PubMed ID: 18995892
[TBL] [Abstract][Full Text] [Related]
12. Interferon-
Henriquez JE; Rizzo MD; Crawford RB; Gulick P; Kaminski NE
J Pharmacol Exp Ther; 2018 Oct; 367(1):49-58. PubMed ID: 30026298
[TBL] [Abstract][Full Text] [Related]
13. Modulation of CD40-activated B lymphocytes by N-acetylcysteine involves decreased phosphorylation of STAT3.
Nadeau PJ; Roy A; Gervais-St-Amour C; Marcotte MÈ; Dussault N; Néron S
Mol Immunol; 2012 Jan; 49(4):582-92. PubMed ID: 22078209
[TBL] [Abstract][Full Text] [Related]
14. Impaired memory B-cell development and antibody maturation with a skewing toward IgE in patients with STAT3 hyper-IgE syndrome.
van de Veen W; Krätz CE; McKenzie CI; Aui PM; Neumann J; van Noesel CJM; Wirz OF; Hagl B; Kröner C; Spielberger BD; Akdis CA; van Zelm MC; Akdis M; Renner ED
Allergy; 2019 Dec; 74(12):2394-2405. PubMed ID: 31269238
[TBL] [Abstract][Full Text] [Related]
15. The effect of delta-9-tetrahydrocannabinol and 11-hydroxy-delta-9-tetrahydrocannabinol on T-lymphocyte and B-lymphocyte mitogen responses.
Klein TW; Newton CA; Widen R; Friedman H
J Immunopharmacol; 1985; 7(4):451-66. PubMed ID: 3003204
[TBL] [Abstract][Full Text] [Related]
16. Δ9-tetrahydrocannabinol suppresses cytotoxic T lymphocyte function independent of CB1 and CB 2, disrupting early activation events.
Karmaus PW; Chen W; Kaplan BL; Kaminski NE
J Neuroimmune Pharmacol; 2012 Dec; 7(4):843-55. PubMed ID: 21789506
[TBL] [Abstract][Full Text] [Related]
17. Functions of CD40 and Its Ligand, gp39 (CD40L).
Laman JD; Claassen E; Noelle RJ
Crit Rev Immunol; 2017; 37(2-6):371-420. PubMed ID: 29773027
[TBL] [Abstract][Full Text] [Related]
18. Differential downstream effects of CD40 ligation mediated by membrane or soluble CD40L and agonistic Ab: a study on purified human B cells.
Cognasse F; Chavarin P; Acquart S; Sabido O; Beniguel L; Genin C; Richard Y; Garraud O
Int J Immunopathol Pharmacol; 2005; 18(1):65-74. PubMed ID: 15698512
[TBL] [Abstract][Full Text] [Related]
19. Distinct modes of action of CD40L and adaptive cytokines IL-2, IL-4/13, IL-10 and IL-21 on rainbow trout IgM
Abos B; Wang T; Secombes CJ; Tafalla C
Dev Comp Immunol; 2020 Oct; 111():103752. PubMed ID: 32447012
[TBL] [Abstract][Full Text] [Related]
20. Murine B1 B cells require IL-5 for optimal T cell-dependent activation.
Erickson LD; Foy TM; Waldschmidt TJ
J Immunol; 2001 Feb; 166(3):1531-9. PubMed ID: 11160193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
